171 related articles for article (PubMed ID: 23351719)
1. High number of CD56(bright) NK-cells and persistently low CD4+ T-cells in a hemophiliac HIV/HCV co-infected patient without opportunistic infections.
Fregni G; Maresca AF; Jalbert V; Caignard A; Scott-Algara D; Cramer EB; Rouveix E; Béné MC; Capron C
Virol J; 2013 Jan; 10():33. PubMed ID: 23351719
[TBL] [Abstract][Full Text] [Related]
2. CD56
Judge CJ; Kostadinova L; Sherman KE; Butt AA; Falck-Ytter Y; Funderburg NT; Landay AL; Lederman MM; Sieg SF; Sandberg JK; Anthony DD
J Leukoc Biol; 2017 Jul; 102(1):171-184. PubMed ID: 28400540
[TBL] [Abstract][Full Text] [Related]
3. Liver cirrhosis in HIV/HCV-coinfected individuals is related to NK cell dysfunction and exhaustion, but not to an impaired NK cell modulation by CD4
Polo ML; Ghiglione YA; Salido JP; Urioste A; Poblete G; Sisto AE; Martinez A; Rolón MJ; Ojeda DS; Cahn PE; Turk GJ; Laufer NL
J Int AIDS Soc; 2019 Sep; 22(9):e25375. PubMed ID: 31536177
[TBL] [Abstract][Full Text] [Related]
4. NK cells of HIV-1-infected patients with poor CD4
Giuliani E; Vassena L; Di Cesare S; Malagnino V; Desimio MG; Andreoni M; Barnaba V; Doria M
Immunol Lett; 2017 Oct; 190():185-193. PubMed ID: 28826739
[TBL] [Abstract][Full Text] [Related]
5. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R
AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303
[TBL] [Abstract][Full Text] [Related]
6. Increased frequency of CD56Bright NK-cells, CD3-CD16+CD56- NK-cells and activated CD4+T-cells or B-cells in parallel with CD4+CDC25High T-cells control potentially viremia in blood donors with HCV.
Zarife MA; Reis EA; Carmo TM; Lopes GB; Brandão EC; Silva HR; Santana N; Martins-Filho OA; Reis MG
J Med Virol; 2009 Jan; 81(1):49-59. PubMed ID: 19031471
[TBL] [Abstract][Full Text] [Related]
7. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
[TBL] [Abstract][Full Text] [Related]
8. Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset.
Mantegani P; Tambussi G; Galli L; Din CT; Lazzarin A; Fortis C
Immunology; 2010 Feb; 129(2):220-33. PubMed ID: 19824914
[TBL] [Abstract][Full Text] [Related]
9. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
[TBL] [Abstract][Full Text] [Related]
10. Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections.
Meier UC; Owen RE; Taylor E; Worth A; Naoumov N; Willberg C; Tang K; Newton P; Pellegrino P; Williams I; Klenerman P; Borrow P
J Virol; 2005 Oct; 79(19):12365-74. PubMed ID: 16160163
[TBL] [Abstract][Full Text] [Related]
11. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.
Tarazona R; Casado JG; Delarosa O; Torre-Cisneros J; Villanueva JL; Sanchez B; Galiani MD; Gonzalez R; Solana R; Peña J
J Clin Immunol; 2002 May; 22(3):176-83. PubMed ID: 12078859
[TBL] [Abstract][Full Text] [Related]
12. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
[TBL] [Abstract][Full Text] [Related]
13. Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy.
Yokozaki S; Takamatsu J; Nakano I; Katano Y; Toyoda H; Hayashi K; Hayakawa T; Fukuda Y
Blood; 2000 Dec; 96(13):4293-9. PubMed ID: 11110704
[TBL] [Abstract][Full Text] [Related]
14. Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.
Bhardwaj S; Ahmad F; Wedemeyer H; Cornberg M; Schulze Zur Wiesch J; van Lunzen J; Sarin SK; Schmidt RE; Meyer-Olson D
Virol J; 2016 Apr; 13():67. PubMed ID: 27091211
[TBL] [Abstract][Full Text] [Related]
15. CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C.
Kokordelis P; Krämer B; Boesecke C; Voigt E; Ingiliz P; Glässner A; Wolter F; Srassburg CP; Spengler U; Rockstroh JK; Nattermann J
J Acquir Immune Defic Syndr; 2015 Dec; 70(4):338-46. PubMed ID: 26509931
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
[TBL] [Abstract][Full Text] [Related]
17. Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda.
Naluyima P; Eller MA; Laeyendecker O; Quinn TC; Serwadda D; Sewankambo NK; Gray RH; Michael NL; Wabwire-Mangen F; Robb ML; Sandberg JK
AIDS; 2014 Jun; 28(9):1273-8. PubMed ID: 24959961
[TBL] [Abstract][Full Text] [Related]
18. Timing of Antiretroviral Therapy Initiation Determines Rectal Natural Killer Cell Populations.
Utay NS; Vigil KJ; Somasunderam A; Aulicino PC; Smulevitz B; Chiadika S; Wolf DS; Kimata JT; Arduino RC
AIDS Res Hum Retroviruses; 2020 Apr; 36(4):314-323. PubMed ID: 31838858
[TBL] [Abstract][Full Text] [Related]
19. No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Multivirc Group.
Cacoub P; Musset L; Hausfater P; Ghillani P; Fabiani FL; Charlotte F; Angevin E; Opolon P; Poynard T; Piette JC; Autran B
Clin Exp Immunol; 1998 Jul; 113(1):48-54. PubMed ID: 9697982
[TBL] [Abstract][Full Text] [Related]
20. The frequency, activation, and coreceptor expression of lymphocytes in human immunodeficiency virus/hepatitis C virus co-infected patients in China.
Shi W; Zhang Z; Zhang M; Liu J; Jiang Y; Wang Y; Jin X; Han X; Shang H
Jpn J Infect Dis; 2009 Jul; 62(4):284-8. PubMed ID: 19628906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]